compound glp-1 side effects glp 1 gip gip medications long term effects Managing Side Effects of GLP-1 Receptor Agonists – Transformation GLP-1 is made in your

Acknowledgments This work was supported in part by grants PUJ IDs 4509 and 4327 to GEB

Kolterman, O

This phenomenon represents a form of neuropathic pain where the nervous system processes non-painful stimuli as painful signals

Key limitations of current evidence include: Relatively short follow-up periods (typically 35 years) in randomised trials, whereas pancreatic cancer may take years to develop Potential for detection bias, as patients on GLP-1 therapy may undergo more frequent medical monitoring Difficulty accounting for all confounding factors in observational studies Despite these limitations, the weight of current evidence does not support a causal link between GLP-1 receptor agonist use and pancreatic cancer development

The mirror is nicer to you